To gain insight into the changes in serum antioxidant and anti-inflammatory activities associated with obesity/GDM, we examined the activity of the HDL-associated enzyme PON1 and the total antioxidative capacity of serum. The gene discussed is PON1; the disease is obesity due to melanocortin 4 receptor deficiency.